These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5874720)

  • 21. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. II. A possible mechanism for potentiation of the carcinostatic activity of alkylating agents by ferrous glucuronate.
    Hano K; Akashi A
    Gan; 1965 Aug; 56(4):385-402. PubMed ID: 4954025
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapeutic effects of compound 593A (NSC-135758) on mouse leukemias and some transplanted animal tumors.
    Tarnowski GS; Schmid FA; Hutchison DJ; Stock CC
    Cancer Chemother Rep; 1973 Feb; 57(1):21-7. PubMed ID: 4704098
    [No Abstract]   [Full Text] [Related]  

  • 23. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. I. Combination therapy with anticancer agents and iron compounds.
    Hano K; Akashi A
    Gan; 1965 Aug; 56(4):377-84. PubMed ID: 4954024
    [No Abstract]   [Full Text] [Related]  

  • 24. Proceedings: On the number, reactivity and function of SH groups at the surface of Ehrlich ascites tumor cells.
    Löffler M; Schneider F
    Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1225. PubMed ID: 4477749
    [No Abstract]   [Full Text] [Related]  

  • 25. Spectrum and selectivity of antitumor action of phenesterin.
    Degteva SA
    Fed Proc Transl Suppl; 1965; 24(6):1111-2. PubMed ID: 5215182
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental study on thermodifferential chemotherapy of carcinoma (author's transl)].
    Kamura T; Kidera Y; Aoki K; Nishikawa K; Baba T
    Fukuoka Igaku Zasshi; 1977 Oct; 68(10):492-7. PubMed ID: 590913
    [No Abstract]   [Full Text] [Related]  

  • 27. [Autoradiographic research on the cell generation cycle of the Ehrlich ascites carcinoma in the white mouse].
    OEHLERT W; SEEMAYER N; LAUF P
    Beitr Pathol Anat; 1962 Oct; 127():63-78. PubMed ID: 13939484
    [No Abstract]   [Full Text] [Related]  

  • 28. Activity of cyclophosphamide and 1-methylnitrosourea on Ehrlich carcinoma transplanted in different sites. Correlation between drug level and tumor inhibition.
    Bossi A; Colombo T; Donelli MG; Garattini S
    Biochem Pharmacol; 1975 Jan; 24(1):21-6. PubMed ID: 1122258
    [No Abstract]   [Full Text] [Related]  

  • 29. Mixed bifunctionality. II. Relation of antitumor activity to structure in alkylating agents derived from polynuclear aromatic hydrocarbons.
    Peck RM; O'Connell AP; Creech HJ
    J Med Chem; 1970 Mar; 13(2):284-8. PubMed ID: 5418503
    [No Abstract]   [Full Text] [Related]  

  • 30. [COMPARATIVE STUDIES ON CYTOSTATIC ALKYLATING REACTIONS].
    WEITZEL G; SCHNEIDER F; FRETZDORFF AM; SEYNSCHE K; FINGER H
    Krebsforsch Krebsbekampf; 1964; 30():156-63. PubMed ID: 14283701
    [No Abstract]   [Full Text] [Related]  

  • 31. [Autoradiography studies of cell proliferation and the effect of cytostatic agents on the proliferation of normal and tumor cells].
    Maurer-Schultze B
    Acta Histochem Suppl; 1983; 27():9-30. PubMed ID: 6191361
    [No Abstract]   [Full Text] [Related]  

  • 32. [THE EFFECT OF ALKYLATING CYTOSTATICS ON THE NUCLEIC ACID METABOLISM OF EHRLICH ASCITES TUMOR CELLS].
    LISS E; PALME G
    Z Krebsforsch; 1964 Jul; 66():196-206. PubMed ID: 14256642
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of alkylating antitumor agents on the binding of DNA to protein.
    Grunicke H; Bock KW; Becher H; Gäng V; Schnierda J; Puschendorf B
    Cancer Res; 1973 May; 33(5):1048-53. PubMed ID: 4349930
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of the alkylating antitumor agent 2,3,5-tris(ethyleneimino)benzoquinone with the plasma membrane of Ehrlich ascites tumor cells.
    Ihlenfeldt M; Gantner G; Harrer M; Puschendorf B; Putzer H; Grunicke H
    Cancer Res; 1981 Jan; 41(1):289-93. PubMed ID: 6256062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AUTORADIOGRAPHIC INVESTIGATION OF THE MITOTIC CYCLE OF EHRLICH ASCITES TUMOR CELLS IN VIVO. ANL-6723.
    BASERGA R; KISIELESKI WE
    ANL Rep; 1963 May; ():203-4. PubMed ID: 14131014
    [No Abstract]   [Full Text] [Related]  

  • 36. Potential antitumor agents: steroidal amidoesters with an alkylating moiety.
    Papageorgiou A; Boutis L; Nicolaropoulos S; Catsoulacos P
    Oncology; 1987; 44(2):128-32. PubMed ID: 3574853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methods of screening anticancer drugs in the soviet union.
    Larionov LF
    Cancer Chemother Rep; 1970 Apr; 54(2):71-7. PubMed ID: 5527014
    [No Abstract]   [Full Text] [Related]  

  • 38. Lack of correlation between the carcinostatic effect and the inhibition of glycolysis caused by tris-(beta-chlorethyl)-amine.
    Svec J; Sauermann G
    Chemotherapy; 1970; 15(1):12-8. PubMed ID: 4245149
    [No Abstract]   [Full Text] [Related]  

  • 39. Nucleolar alterations in ascites tumour cells induced by 5-fluorouracil treatment.
    Kopper L; Kiss J; Lapis K
    Neoplasma; 1973; 20(3):225-30. PubMed ID: 4725512
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies on the mechanism of action of endoxan].
    Grunicke H; Liersch M; Holzer H; Arnold H
    Biochem Pharmacol; 1965 Nov; 14(11):1485-90. PubMed ID: 4286382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.